PROLONGED ADMINISTRATION OF A BISPECIFIC ANTIBODY CONSTRUCT BINDING TO CD33 AND CD3

MA53325AUndetermined Publication Date: 2021-06-09AMGEN INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA53325
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-07-30
Filing Date
2019-07-29
Publication Date
2021-06-09
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.